You are here:

Pfizer Ltd

Name SMC ID No Status Sub. Type
 
anidulafungin (Ecalta) 465/08 Not Recommended Full submission
anidulafungin (Ecalta) 465/08 Restricted Resubmission
atorvastatin (Lipitor) 766/12 Accepted Abbreviated Submission
Atorvastatin (Lipitor®) 202/05 Restricted Abbreviated Submission
axitinib (Inlyta) 855/13 Not Recommended Full submission
axitinib (Inlyta) 855/13 Accepted Resubmission
bosutinib (Bosulif) 910/13 Not Recommended Full submission
bosutinib (Bosulif) 910/13 Accepted Resubmission
ceftaroline fosamil (Zinforo) 1306/18 Not Recommended Non submission
ceftazidime avibactam (Zavicefta) 1307/18 Not Recommended Non submission
celecoxib (Celebrex) 410/07 Not Recommended Non submission
collagenase (Xiapex) 715/11 Superseded Resubmission
collagenase clostridium histolyticum (Xiapex) 715/11 Not Recommended Full submission
crizotinib (Xalkori) 865/13 Not Recommended Full submission
crizotinib (Xalkori) 865/13 Accepted Resubmission
crizotinib (Xalkori) 1152/16 Accepted Full submission
dalteparin (Fragmin) 683/11 Restricted Full submission
eplerenone (Inspra) 793/12 Accepted Full submission
Eplerenone (Inspra®) 136/04 Accepted Resubmission
Eplerenone (Inspra®) 136/04 Restricted Full submission
etanercept (Enbrel) 782/12 Superseded Abbreviated Submission
etanercept (Enbrel) 842/13 Restricted Abbreviated Submission
etanercept (Enbrel) 781/12 Superseded Abbreviated Submission
Exemestane 25mg tablets (Aromasin®) 210/05 Superseded Full submission
fesoterodine fumarate (Toviaz) 480/08 Restricted Full submission
inhaled insulin, 1mg and 3mg inhalation powder (Exubera) 254/06 Withdrawn Full submission
Latanoprost (Xalatan) 102/04 Restricted Full submission
latanoprost timolol maleate (Xalacom) 432/07 Accepted Abbreviated Submission
maraviroc (Celsentri) 458/08 Not Recommended Full submission
maraviroc (Celsentri) 458/08 Not Recommended Resubmission
medroxyprogesterone acetate (Sayana Press) 896/13 Accepted Abbreviated Submission
palbociclib (Ibrance) 1276/17 Restricted Full submission
Pegaptanib (Macugen) 290/06 Superseded Full submission
Pegvisomant (Somavert) 158/05 Not Recommended Resubmission
pegvisomant (Somavert) 158/05 Accepted Resubmission
Pegvisomant (Somavert®) 158/05 Not Recommended Full submission
pregabalin (Lyrica) 157/05 Restricted Resubmission
pregabalin (Lyrica) 339/06 Not Recommended Non submission
Pregabalin (Lyrica®) 145/04 Restricted Full submission
Pregabalin 25, 50, 75, 100, 150, 200 and 300mg capsules (Lyrica) 157/05 Not Recommended IRP
Pregabalin 25mg, 50mg, 75mg, 100mg, 150mg, 200mg and 300mg capsules (Lyrica®) 157/05 Not Recommended Full submission
pregabalin oral solution (Lyrica) 765/12 Restricted Abbreviated Submission
Pregabalin, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg and 300mg capsules (Lyrica®) 157/05 Not Recommended Resubmission
pregabalin, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg capsules (Lyrica) 389/07 Not Recommended Full submission
Sertraline (Lustral®) 68/03 Not Recommended Full submission
sildenafil (Revatio) 596/10 Restricted Full submission
sildenafil (Revatio) 809/12 Restricted Abbreviated Submission
sildenafil (Revatio) IV 688/11 Restricted Abbreviated Submission
Sildenafil citrate 20mg tablets (Revatio®) 235/06 Restricted Full submission
Somatropin (Genotropin®) injection 240/06 Superseded Abbreviated Submission
sunitinib (Sutent) 275/06 Accepted Resubmission
sunitinib (Sutent) 698/11 Superseded Full submission
sunitinib 12.5mg, 25mg, 50mg capsules (Sutent) 384/07 Superseded Full submission
sunitinib 50mg capsule (Sutent) 275/06 Not Recommended Full submission
sunitinib 50mg capsule (Sutent) 343/07 Not Recommended Full submission
tafamidis meglumine (Vyndaqel) 877/13 Not Recommended Non submission
tigecycline (Tygacil) 1101/15 Not Recommended Non submission
tofacitinib (Xeljanz) 1298/18 Restricted Full submission
Valdecoxib (Bextra®) 89/04 Advice has been withdrawn from the Website Full submission
varenicline 1mg tablets (Champix) 336/06 Accepted Full submission
voriconazole (Vfend) 1014/14 Not Recommended Non submission
Voriconazole (VFEND®) 25/02 Restricted Full submission
Voriconazole (VFEND®) 142/04 Restricted Abbreviated Submission
Voriconazole 50mg and 200mg tablets, 40mg/ml oral suspension, and 200mg vials (Vfend®) for infusion 194/05 Restricted Full submission

Back